The global mannan oligosaccharide market is anticipated to witness growth over the forecast period. Increasing demand for livestock on account of rising consumption of animal based nutritional products is expected to act as a driving factor for global mannan oligosaccharide (MOS) market over the forecast period. MOS is a prebiotic functional ingredient, used for improving gastrointestinal function as well as preventing the occurrence of digestive diseases by limiting development of pathogenic bacteria. On account of aforementioned properties, MOS is increasingly used as a nutritional supplement for feeding dogs, poultry, bovine, swine and aquaculture species. Rising demand for prebiotic ingredients in nutritional industry on account of improving gut health is expected to promote MOS market demand in the fortification of dietary supplements over the forecast period. Market presence of other prebiotic ingredients such as inulin, FOS and XOS is expected to pose a credible threat for MOS market. Rising importance of herbal extract ingredients such as phytogenic in animal feed industry is expected to hamper MOS market over the forecast period. European Commission imposed a ban on antibiotic growth promoters as animal feed on account of increasing drug count and posing harmful effect to livestock immune system. The U.S. EPA and government of South Korea also announced the ban on antibiotics in 2011 and 2012, respectively. Regulatory inclination intended for restricting the application of antibiotics in animal feed industry is expected to be a favorable factor for the market over the forecast period.
MOS plays an important role in supporting balanced microflora in the gut when provided as animal feed. Rising importance of improved breeding for the production of bovine, swine and poultry species is expected to fuel mannan oligosaccharide market in the near future. Animal feed industry growth in on account of increasing consumption of animal derived nutritional products is anticipated to remain major driver for MOS market in the near future. In March 2015, the European Commission lifted the ban on dairy products which is expected to augment domestic milk manufacturers to increase their production capacities. As a result, Increase in production of dairy products is expected to augment animal feed industry growth and thus likely to fuel mannan oligosaccharide market (MOS) market demand over the forecast period. Growing importance of aquaculture on account of increasing human direct consumption coupled with increasing demand for fish oil in industrial applications is expected to promote market growth over the next seven years.
Asia Pacific is expected to be one of the largest markets for MOS over the forecast period. Robust manufacturing base of meat production in China, India and Australia is expected to promote animal feed industry which is expected to fuel mannan oligosaccharide market demand. Dairy industry growth in New Zealand, Australia and India is expected to increase the cattle farming which is expected to augment MOS market growth. Rising importance of naturally derived ingredients in animal feed industry in Europe on account of ban imposed on synthetically derived products such as antibiotics is expected to have a positive impact on mannan oligosaccharide (MOS) market over the forecast period. Growing production of red meats such as beef and pork in Brazil on account of growing domestic consumption is expected to augment animal feed industry and is expected to fuel MOS market demand over the forecast period. Middle East is expected to be a lucrative market over the forecast period on account of growing animal feed industry in light of rising consumption of beef and technological advancement. Meat producers such as Tyson Foods, Perdue Farms and Foster Farms have started to deploy the use of naturally derived ingredients such as MOS in animal feed for cattle farming.
Major manufacturers in mannan oligosaccharide market include Royal Canin, Biofeed Technology, ORFFA, MItushi Pharma, Nutriteck, Lallemand and Fubon. New product developments along with establishment of strategic partnerships with buyers are expected to remain a critical success factor for MOS market players in the near future. Increasing bio-based ethanol production in the U.S. and Brazil on account of regulatory inclination to reduce green house emissions is expected to restrict the availability of yeast as raw material for MOS production over the forecast period. In January 2014, Protexin Veterinary launched new pet care product comprising MOS, under the brand name, CystoPro, for improving urinary tract function in dogs. This product launch is expected to force other pet care products manufacturers to deploy the use of MOS in their offerings to improve urinary tract function.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."